How many insider trades does FilingIQ track for LBRX?

FilingIQ tracks 15 Form 4 insider transactions for LBRX (LB PHARMACEUTICALS INC), covering filings from Sep 12, 2025 onwards. 1 of those were filed in the last 90 days.

Are LBRX insiders net buyers or net sellers?

Across the full Form 4 history for LBRX, 8 transactions (53%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does LBRX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is LBRX in?

LB PHARMACEUTICALS INC (LBRX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $602.88M.

LBRX insider trading

Healthcare

LB PHARMACEUTICALS INC — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

53% / 0%

Market cap

$602.88M

About LB PHARMACEUTICALS INC

LB Pharmaceuticals Inc, a clinical-stage biopharmaceutical company, develops therapies for the treatment of schizophrenia, bipolar depression, and other neuropsychiatric diseases. Its lead product is LB-102, a small molecule oral product, which is in Phase 3 clinical trial for the treatment of acute schizophrenia; completed Phase 1 clinical trial for the treatment of bipolar I depression; and in pr clinical stage for the treatment of LAI formulation. The company was incorporated in 2015 and is headquartered in New York, New York.

Company website: lbpharma.us

LBRX insider activity at a glance

FilingIQ has scored 15 insider transactions for LBRX since Sep 12, 2025. The most recent filing in our index is dated Mar 6, 2026.

Across the full history, 8 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on LBRX insider trades is 66.7/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live LBRX trades on FilingIQ Raw filings on SEC EDGAR

Latest LBRX Form 4 filings

Nussbaum Ran

P Sep 12, 2025

Pontifax Management 4 G.P. (2015) Ltd.

P Sep 12, 2025

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for LBRX?: FilingIQ tracks 15 Form 4 insider transactions for LBRX (LB PHARMACEUTICALS INC), covering filings from Sep 12, 2025 onwards. 1 of those were filed in the last 90 days.
Are LBRX insiders net buyers or net sellers?: Across the full Form 4 history for LBRX, 8 transactions (53%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does LBRX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is LBRX in?: LB PHARMACEUTICALS INC (LBRX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $602.88M.

Methodology & sources

Every LBRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.